Bradykinin-mediated angioedema can be further classified as hereditary angioedema (HAE), acquired angioedema, or angiotensin-converting enzyme (ACE) inhibitor-induced angioedema (ACEi-AE) [2]. This evidence concerns the gene ACE and acrodermatitis enteropathica.